Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician.
Journal Article (Journal Article;Review)
Patients with prosthetic heart valves require chronic oral anticoagulation. In this clinical scenario, physicians must be mindful of the thromboembolic and bleeding risks related to chronic anticoagulant therapy. Currently, only vitamin K antagonists are approved for this indication. This paper reviews the main heart valve guidelines focusing on the use of oral anticoagulation in these patients.
Full Text
Duke Authors
Cited Authors
- Leiria, TLL; Lopes, RD; Williams, JB; Katz, JN; Kalil, RAK; Alexander, JH
Published Date
- May 2011
Published In
Volume / Issue
- 31 / 4
Start / End Page
- 514 - 522
PubMed ID
- 21327503
Pubmed Central ID
- PMC3699194
Electronic International Standard Serial Number (EISSN)
- 1573-742X
Digital Object Identifier (DOI)
- 10.1007/s11239-011-0574-9
Language
- eng
Conference Location
- Netherlands